Breastfeeding moms needed to test COVID pill transfer into milk
NCT ID NCT05441215
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study looked at how much of the COVID-19 treatment nirmatrelvir/ritonavir (Paxlovid) passes into breast milk. Eight healthy breastfeeding women took the medicine by mouth three times over two days. Researchers collected breast milk samples to measure drug levels and check safety. The goal is to help doctors give better advice to breastfeeding mothers who need this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - Brussels
Brussels, Bruxelles-capitale, Région de, B-1070, Belgium
Conditions
Explore the condition pages connected to this study.